Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Gutsche

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Medicine & Research|November 14, 2013
Authors' replyMarkus Gutsche, Ware Kuschner
Clinical Medicine & Research|April 28, 2012
Hemoptysis due to breath-hold diving following chemotherapy and lung irradiationMarkus Gutsche, Ware G Kuschner
Current Respiratory Care Reports|November 6, 2012
Connective Tissue Disease-associated Interstitial Lung Disease: A reviewMarkus Gutsche, Glenn D Rosen, Jeffrey J Swigris
Cureus|September 4, 2023
Calcium Channel Blocker-Induced Thrombocytopenia in the Intensive Care Unit: A Rare Presentation and Review of the LiteratureAllen Zhou, Michael Sandhu, Brian Min, et al.
Frontiers in Pharmacology|January 9, 2019
South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)Shaney L Barratt, Sarah Mulholland, Khaled Al Jbour, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Medicine & Research|November 14, 2013
Authors' replyMarkus Gutsche, Ware Kuschner
Clinical Medicine & Research|April 28, 2012
Hemoptysis due to breath-hold diving following chemotherapy and lung irradiationMarkus Gutsche, Ware G Kuschner
Current Respiratory Care Reports|November 6, 2012
Connective Tissue Disease-associated Interstitial Lung Disease: A reviewMarkus Gutsche, Glenn D Rosen, Jeffrey J Swigris
Cureus|September 4, 2023
Calcium Channel Blocker-Induced Thrombocytopenia in the Intensive Care Unit: A Rare Presentation and Review of the LiteratureAllen Zhou, Michael Sandhu, Brian Min, et al.
Frontiers in Pharmacology|January 9, 2019
South-West of England's Experience of the Safety and Tolerability Pirfenidone and Nintedanib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)Shaney L Barratt, Sarah Mulholland, Khaled Al Jbour, et al.
Pageof 1